TIGIT and glioblastoma: Lucca and colleagues also found that PD-1/PD-L1 expression levels were comparable between GBM and multiple sclerosis, suggesting that TIGIT is likely exerting its own unique inhibitory effect in the TME regardless of heavy co-expression with other ICs (170–172).